ARANA THERAPEUTICS LIMITED
AAH - Commencement of Phase II Trials for Lead Compound ART621 - Dr John Chiplin, CEO and Managing Director and Dr David Fuller, Chief Medical Officer
Tue, 18 Mar 2008 02:00PM
Click to listen to audio on your default player or
Download the latest version of the Flash Player
Dr John Chiplin and Dr David Fuller
Tue, 18 Mar 2008
02:00PM Australia/NSW
Select a tab above to display more information
 NOVOGEN LIMITED
(NRT)
|
NRT - Healthy Investment eConference - Christopher Naughton, Managing Director Wed, 1 Jul 2009 12:00PM |
    |
 BIONOMICS LIMITED
(BNO)
|
BNO - Healthy Investment eConference - Dr Deborah Rathjen, CEO and Managing Director Wed, 1 Jul 2009 11:00AM |
|
 BIOPHARMICA LIMITED
(BPH)
|
BPH - Healthy Investment eConference Wed, 1 Jul 2009 10:00AM |
|
ARANA THERAPEUTICS LIMITED (AAH)
ASX code: AAH
Website: http://www.arana.com
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
A biopharmaceutical company focused on developing next generation antibody based drugs that will improve the lives of patients with inflammatory diseases and cancer.
Address:
, 37 Epping Road, Level 2,
MACQUARIE PARK
NSW
Phone: 02 8061 9900
Fax: 02 8061 9999
Executives & Directors
Mr Robin Beaumont , Chairman
Mr Gordon Black , Non Exec. Director
Dr Lincoln Chee , Non Exec. Director
Mr Chris Harris , Non Exec. Director, Independent Director
Mr Niall Henderson , CFO
Mr Niall Henderson , Company Secretary
Company Podcasts
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Please refer to the relevant stock exchange if any of the above information is incorrect
ARANA THERAPEUTICS LIMITED (AAH) Events
Australia/NSW
ARANA THERAPEUTICS LIMITED (AAH)
| Suspension from Official Quotation at close 02/07/09 | Thu, 2 Jul 2009 |
| Cephalon Takeover Bid | Tue, 30 Jun 2009 |
| Change in substantial holding | Mon, 29 Jun 2009 |
| Form 6021 - Compulsory Acquisition following T/O bid | Thu, 25 Jun 2009 |
| Change in substantial holding | Tue, 23 Jun 2009 |
| Appendix 3B - 2009 Performance Share Plan | Wed, 17 Jun 2009 |
| Cephalon T/O - Increase Consideration/Extension Offer Period | Mon, 15 Jun 2009 |
| Change in substantial holding | Mon, 15 Jun 2009 |
| Cephalon has relevant interest in 90.41% of Shares | Mon, 15 Jun 2009 |
| Change in substantial holding | Thu, 11 Jun 2009 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.
